52-Week Performance Chart

Powered by FactSet Research Systems Inc

No DR Special Notices are available.

No DR Events are available.

Data provided by Thomson Reuters

Institutional Ownership

TOP INSTITUTIONAL HOLDERS POSITION
Jennison Associates LLC 18,885,343
Loomis, Sayles & Co. LP 12,576,031
Capital Research & Management Co. (International Investors) 11,621,232
TOP MUTUAL FUND HOLDERS POSITION
Harbor Capital Appreciation Fund 4,108,787
Loomis Sayles Growth Fund 3,440,597
Washington Mutual Investors Fund 3,320,000

Data provided by FactSet Research Systems Inc.

DR Details

DR Symbol NVO
CUSIP 670100205
DR Venue New York Stock Exchange
DR ISIN US6701002056
Ratio DR:ORD 1:1
Underlying ISIN DK0060102614
Country Denmark
Effective Date Jun 03, 1991
Depositary JPMC (Sponsored)
Industry Pharma. & Biotech.
Novo Nordisk A/S is a global healthcare company engaged in diabetes care. The Company is also engaged in the discovery, development, manufacturing and marketing of pharmaceutical products. The Company operates through two business segments: diabetes and obesity care, and biopharmaceuticals. The Company's diabetes and obesity care segment covers insulin, GLP-1, other protein-related products, such as glucagon, protein-related delivery systems and needles, and oral anti-diabetic drugs. The Company's biopharmaceuticals segment covers the therapy areas of hemophilia care, growth hormone therapy and hormone replacement therapy. The Company also offers Saxenda product to treat obesity.

Data provided by Mergent, Inc.

Fee Type in US Dollar per ADS Deposit Agreement
Cable Fee per Cancellation $17.5000

Monthly Trading Summary

More
Month Month End DR Close Price DR Trading Volume Avg Day DR Trading Volume
Jul.25 47.07 370,718,272 16,850,831
Jun.25 69.02 185,970,629 9,298,531
May.25 71.50 238,923,379 11,377,304

Powered by FactSet Research Systems Inc.

This information and data is provided for general informational purposes only.  Certain displayed prices may not reflect direct quotes from any market or exchange, but may instead reflect an approximation of price based on a methodology that includes a calculation that includes the price of underlying securities and foreign exchange rate selected for such purpose. The Bank of New York Mellon and our information suppliers do not warrant or guarantee the accuracy, timeliness or completeness of this information or data. We provide no advice nor recommendation or endorsement with respect to any company or securities. We do not undertake any obligation to update or amend this information or data. Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.
Please refer to Terms of Use

DEPOSITARY RECEIPTS:
NOT FDIC, STATE OR FEDERAL AGENCY INSURED
MAY LOSE VALUE
NO BANK, STATE OR FEDERAL AGENCY GUARANTEE